New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 16, 2012
17:43 EDTOFIXOrthofix concludes bone growth stimulator investigation
Orthofix International announced that it has resolved all matters related to the investigation of its bone growth stimulation business. Consistent with the agreement in principle that the Company previously announced in May 2011, the Company will pay approximately $43 million to resolve all civil and criminal matters, which included a plea to obstruction of a June 2008 federal audit. These charges were previously recorded in the first quarter of 2011. As part of the resolution, the Court imposed a five-year term of probation, during which the Company must continue to comply with the terms of its previously-executed Corporate Integrity Agreement. This final settlement also includes the resolution of a related qui tam complaint filed against the Company, which remains pending against several of its competitors.
News For OFIX From The Last 14 Days
Check below for free stories on OFIX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
May 9, 2013
12:30 EDTOFIXOrthofix downgraded to Sell from Buy at Lazard Capital
Subscribe for More Information
10:08 EDTOFIXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:45 EDTOFIXOrthofix downgraded to Neutral from Buy at Janney Capital
Subscribe for More Information
06:44 EDTOFIXOrthofix downgraded to Market Perform from Outperform at JMP Securities
JMP Securities downgraded Orthofix due to the disappointing Q1 report.
06:25 EDTOFIXOrthofix downgraded to Neutral from Buy at Mizuho
Subscribe for More Information
May 8, 2013
16:08 EDTOFIXOrthofix sees Q2 revenue $104M-$107M, consensus $119.73M
Subscribe for More Information
16:07 EDTOFIXOrthofix reports Q1 adjusted EPS 23c, consensus 66c
Reports Q1 revenue $100.3M, consensus $11.22M.
16:07 EDTOFIXOrthofix board authorizes $50M share repurchase program
The Orthofix board has authorized a share repurchase program allowing the company to repurchase up to $50M of the company’s common stock, effective beginning May 10.

Sign up for a free trial to see the rest of the stories you've been missing.